Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …
A vaccine for tuberculosis, developed by the Oxford University, has started undergoing clinical trials, making a new vaccine for the disease a possibility. More than two billion people are infected with tuberculosis, which means approximately one out of every three people on the planet. Tuberculosis infects over nine million people …
Unveils new range of over-the-counter products Special Correspondent NEW DELHI: Hamdard (Wakf) Laboratories on Tuesday announced its foray into lifestyle wellness space by unveiling the
INDIAN vaccine makers are setting their sights on tapping the growing US market after the Obama Administration committed $300 million for implementing immunisation programmes in the country. Companies like Bharat Biotech, Serum Institute and Biological E, regular suppliers to WHO vaccines programmes, are now looking at entering the US market. …
United Nations: Anti-malaria drugs, more powerful than previous versions, will be put within reach of millions of people in Africa and Asia as part of an initiative launched by the U.N.-backed fund that fights major epidemics.
R. Prasad CHENNAI: The first volunteer for the Phase I prime-boost AIDS vaccine trial, which will have a duration of two years, has been enrolled by the Tuberculosis Research Centre (TRC) here.
Indians are not guinea pigs INDIA has become an attractive destination for clinical research and drug trials. On an average in a month 25 to 30 companies seek the drug controllers
GlaxoSmithKline and Pfizer plan to combine their HIV-drug units into a new company that will control almost 20% of the market for treating the deadly virus. London-based Glaxo will hold 85% of the joint venture and Pfizer the remainder, the drugmakers said in a statement on Thursday. The new company …
Civil society groups dejected, mull PIL; setback also for Wockhardt. Joe C Mathew / Bangalore April 17, 2009, 0:14 IST The patent office has upheld the validity of Roche
Hoping to challenge Gilead Sciences, the leader in H.I.V. drugs, the pharmaceutical giants GlaxoSmithKline and Pfizer said Thursday that they would form a specialty company to research, develop and market treatments for H.I.V., the virus that causes AIDS. By combining products from both companies, the new entity would have 11 …
Hong Kong: Scientists in Hong Kong and the United States have identified a synthetic compound which appears to be able to stop the replication of influenza viruses, including the H5N1 bird flu virus. The search for such new
Amended Law Proposes Imprisonment For Officials Of Errant Companies & Scrapping Of Licence THE government plans to amend the Drugs & Cosmetics Act to slap up to 10 years of imprisonment and cancellation of licence for violating norms for testing drugs on humans in India, a government official said.
Two new drugs hold promise for tuberculosis patients tuberculosis is a common and deadly disease caused by the bacterium Mycobacterium tuberculosis. It leads to 1.6 to 2 million deaths annually. Worse still, most of the bacterial strains are resistant to multiple drugs and their numbers are rising. The class of …
Avian malaria also responsible for decline in vulture numbers diclofenac poisoning may not be the sole cause for the drastic decline of vulture populations in central and south India. A two-year long study says avian malaria had a part to play as well. The population of the Indian white-backed vulture …
Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has issued directions to enforcement agencies to recover around Rs 116 crore from 31 pharmaceutical firms, including Dr Reddy
